Nir Sassi has been appointed Chief Financial Officer at Intec Pharma Ltd effective August 1, 2016. Until this date, he will continue to hold the Vice President - Finance role at the Company. He holds a Bachelors degree in Accounting and Economics from Ben Gurion University. He is a Certified Chartered Accountant.
Nir Sassi is 41, he's been the Chief Financial Officer of Intec Parent Inc since 2016. There are 8 older and no younger executives at Intec Parent Inc. The oldest executive at Intec Parent Inc is John Kozarich, 70, who is the Chairman of the Board.
Nir's mailing address filed with the SEC is C/O INTEC PHARMA LTD., 12 HARTOM STREET, JERUSALEM, L3, 9777512.
Over the last 6 years, insiders at Intec Parent Inc have traded over $284,445 worth of Intec Parent Inc stock and bought 245,000 units worth $117,350 . The most active insiders traders include Pharma Technologies Ltd.Ore..., Roger Pomerantz oraz Jeffrey A Meckler. On average, Intec Parent Inc executives and independent directors trade stock every 27 days with the average trade being worth of $1,864,936. The most recent stock trade was executed by Pharma Technologies Ltd.Ore... on 31 January 2020, trading 915,951 units of NTEC stock currently worth $283,945.
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.
Intec Parent Inc executives and other stock owners filed with the SEC include: